1. Home
  2. ATAI vs JMSB Comparison

ATAI vs JMSB Comparison

Compare ATAI & JMSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • JMSB
  • Stock Information
  • Founded
  • ATAI 2018
  • JMSB 2005
  • Country
  • ATAI Germany
  • JMSB United States
  • Employees
  • ATAI N/A
  • JMSB N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • JMSB Major Banks
  • Sector
  • ATAI Health Care
  • JMSB Finance
  • Exchange
  • ATAI Nasdaq
  • JMSB Nasdaq
  • Market Cap
  • ATAI 444.7M
  • JMSB 270.0M
  • IPO Year
  • ATAI 2021
  • JMSB N/A
  • Fundamental
  • Price
  • ATAI $4.65
  • JMSB $20.33
  • Analyst Decision
  • ATAI Strong Buy
  • JMSB Buy
  • Analyst Count
  • ATAI 3
  • JMSB 2
  • Target Price
  • ATAI $13.33
  • JMSB $22.50
  • AVG Volume (30 Days)
  • ATAI 4.9M
  • JMSB 13.4K
  • Earning Date
  • ATAI 11-12-2025
  • JMSB 10-22-2025
  • Dividend Yield
  • ATAI N/A
  • JMSB 1.48%
  • EPS Growth
  • ATAI N/A
  • JMSB 688.28
  • EPS
  • ATAI N/A
  • JMSB 1.32
  • Revenue
  • ATAI $2,309,000.00
  • JMSB $56,750,000.00
  • Revenue This Year
  • ATAI $661.36
  • JMSB $18.36
  • Revenue Next Year
  • ATAI N/A
  • JMSB $12.36
  • P/E Ratio
  • ATAI N/A
  • JMSB $15.40
  • Revenue Growth
  • ATAI 510.85
  • JMSB 59.00
  • 52 Week Low
  • ATAI $1.03
  • JMSB $13.81
  • 52 Week High
  • ATAI $5.34
  • JMSB $26.52
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 59.56
  • JMSB 56.60
  • Support Level
  • ATAI $4.50
  • JMSB $20.08
  • Resistance Level
  • ATAI $4.75
  • JMSB $20.85
  • Average True Range (ATR)
  • ATAI 0.31
  • JMSB 0.46
  • MACD
  • ATAI -0.04
  • JMSB 0.02
  • Stochastic Oscillator
  • ATAI 54.14
  • JMSB 68.67

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About JMSB John Marshall Bancorp Inc.

John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.

Share on Social Networks: